Access to ERS Genomics’ foundational CRISPR/Cas9 patent portfolio expands our genetic engineering toolkit and strengthens our ability to speed up and optimize strain development across Dyadic’s ...
ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered ...
In a world-first human trial, Australian researchers have achieved a major milestone in heart disease prevention with a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback